Tabuco, Bj Jhon .
HRN: 17-51-38 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/03/2024
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
11/03/2024
11/10/2024
PO
5 ML
Q12 Hrs
PCAP B
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes